Skip to content

Company · founded 2007

Dicerna Pharmaceuticals (United States)

Cambridge, United States · dicerna.com

Manage this page

Citations, last 5 years: 420
Works, last 5 years: 23
h-index: 69
Scientists listed: 1
Grants since 2016: 6

Grants received

2018–2023 · cooperative agreement · U44

Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders

Bob D. Brown · Dicerna Pharmaceuticals (United States) · funded by National Institutes of Health

$1.5MAlcohol Consumption and Health Effects

2018–2020 · cooperative agreement · U44

Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders

Bob D. Brown · Dicerna Pharmaceuticals (United States) · funded by National Institutes of Health

$1MAlcohol Consumption and Health Effects

2018–2022 · cooperative agreement · U44

Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders

Bob D. Brown · Dicerna Pharmaceuticals (United States) · funded by National Institutes of Health

$1.5MAlcohol Consumption and Health Effects

2018–2020 · cooperative agreement · U44

Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders

Bob D. Brown · Dicerna Pharmaceuticals (United States) · funded by National Institutes of Health

$1MAlcohol Consumption and Health Effects

2016–2018 · research · R44

Optimization of a clinical stage nanoparticle drug delivery platform

Bob D. Brown · Dicerna Pharmaceuticals (United States) · funded by National Institutes of Health

$998.6k

2016–2018 · research · R44

Optimization of a clinical stage nanoparticle drug delivery platform

Bob D. Brown · Dicerna Pharmaceuticals (United States) · funded by National Institutes of Health

$1M